Calls
1
u/Ultpanchu
Reddit r/ValueInvesting
Win Rate
-
return
-
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 20
$23.24
-
The author owns a sizable position in Catalyst Pharmaceuticals and likes it as a medium-term hold, citing high cash with no debt enabling buybacks, high gross/net margins, strong YoY revenue growth (492M in 2024, ~565-585M in 2025), a low ~13 P/E, and ROE/ROIC/ROA of 35-38%/35-36%/22-23%. The newly approved drug AGAMREE is a growth catalyst. Main stated risks are that the core drug Firdapse faces lawsuits and FDA issues, revenue is capped by very niche drugs, and as a small-cap pharma it is subject to investor sentiment.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Ultpanchu has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: CPRX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
